 | • レポートコード：MRC2-11QY04485 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は腎疾患のグローバル市場について調査・分析したレポートです。種類別（急性腎障害、慢性腎疾患、その他）市場規模、用途別（病院、診療所、研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別腎疾患の競争状況、市場シェア ・世界の腎疾患市場：種類別市場規模 2015年-2020年（急性腎障害、慢性腎疾患、その他） ・世界の腎疾患市場：種類別市場規模予測 2021年-2026年（急性腎障害、慢性腎疾患、その他） ・世界の腎疾患市場：用途別市場規模 2015年-2020年（病院、診療所、研究センター、その他） ・世界の腎疾患市場：用途別市場規模予測 2021年-2026年（病院、診療所、研究センター、その他） ・北米の腎疾患市場分析：米国、カナダ ・ヨーロッパの腎疾患市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの腎疾患市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の腎疾患市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの腎疾患市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott (US)、Amgen Inc. (US)、Baxter (US)、Bristol-Myers Squibb Company (US)、Keryx Biopharmaceuticals(US)、NephroGenex(US)、Novartis AG (Switzerland)、Pfizer Inc.(US)、Sanofi (France)、Shire Pharmaceuticals Limited (Republic of Ireland) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Renal disease also known as kidney diseases that affects the functioning of kidneys. According to National Kidney Foundation, Inc., 10% of world’s population is suffering from chronic kidney diseases.
Considering the global scenario of the market, North America is believed to be the largest market for global renal disease. Moreover the European market is the second largest market for global renal disease and Western Europe region is the dominating the market in Europe. On the other hand, Asia-Pacific (APAC) is expected to grow at significant rate in the global renal disease market during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness of disease and treatment.
Market Analysis and Insights: Global Renal Disease Market
The global Renal Disease market size is projected to reach US$ 101050 million by 2026, from US$ 97290 million in 2020, at a CAGR of 3.6%% during 2021-2026.
Global Renal Disease Scope and Market Size
Renal Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Renal Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott (US)
Amgen Inc. (US)
Baxter (US)
Bristol-Myers Squibb Company (US)
Keryx Biopharmaceuticals(US)
NephroGenex(US)
Novartis AG (Switzerland)
Pfizer Inc.(US)
Sanofi (France)
Shire Pharmaceuticals Limited (Republic of Ireland)
Market segment by Type, the product can be split into
Acute Kidney Problems
Chronic Kidney Diseases
Others
Market segment by Application, split into
Hospital
Clinic
Research Center
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Renal Disease Revenue
1.4 Market by Type
1.4.1 Global Renal Disease Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Acute Kidney Problems
1.4.3 Chronic Kidney Diseases
1.4.4 Others
1.5 Market by Application
1.5.1 Global Renal Disease Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Research Center
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Renal Disease Market Perspective (2015-2026)
2.2 Global Renal Disease Growth Trends by Regions
2.2.1 Renal Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Renal Disease Historic Market Share by Regions (2015-2020)
2.2.3 Renal Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Renal Disease Market Growth Strategy
2.3.6 Primary Interviews with Key Renal Disease Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Renal Disease Players by Market Size
3.1.1 Global Top Renal Disease Players by Revenue (2015-2020)
3.1.2 Global Renal Disease Revenue Market Share by Players (2015-2020)
3.1.3 Global Renal Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Renal Disease Market Concentration Ratio
3.2.1 Global Renal Disease Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Renal Disease Revenue in 2019
3.3 Renal Disease Key Players Head office and Area Served
3.4 Key Players Renal Disease Product Solution and Service
3.5 Date of Enter into Renal Disease Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Renal Disease Historic Market Size by Type (2015-2020)
4.2 Global Renal Disease Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Renal Disease Market Size by Application (2015-2020)
5.2 Global Renal Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Renal Disease Market Size (2015-2020)
6.2 Renal Disease Key Players in North America (2019-2020)
6.3 North America Renal Disease Market Size by Type (2015-2020)
6.4 North America Renal Disease Market Size by Application (2015-2020)
7 Europe
7.1 Europe Renal Disease Market Size (2015-2020)
7.2 Renal Disease Key Players in Europe (2019-2020)
7.3 Europe Renal Disease Market Size by Type (2015-2020)
7.4 Europe Renal Disease Market Size by Application (2015-2020)
8 China
8.1 China Renal Disease Market Size (2015-2020)
8.2 Renal Disease Key Players in China (2019-2020)
8.3 China Renal Disease Market Size by Type (2015-2020)
8.4 China Renal Disease Market Size by Application (2015-2020)
9 Japan
9.1 Japan Renal Disease Market Size (2015-2020)
9.2 Renal Disease Key Players in Japan (2019-2020)
9.3 Japan Renal Disease Market Size by Type (2015-2020)
9.4 Japan Renal Disease Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Renal Disease Market Size (2015-2020)
10.2 Renal Disease Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Renal Disease Market Size by Type (2015-2020)
10.4 Southeast Asia Renal Disease Market Size by Application (2015-2020)
11 India
11.1 India Renal Disease Market Size (2015-2020)
11.2 Renal Disease Key Players in India (2019-2020)
11.3 India Renal Disease Market Size by Type (2015-2020)
11.4 India Renal Disease Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Renal Disease Market Size (2015-2020)
12.2 Renal Disease Key Players in Central & South America (2019-2020)
12.3 Central & South America Renal Disease Market Size by Type (2015-2020)
12.4 Central & South America Renal Disease Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott (US)
13.1.1 Abbott (US) Company Details
13.1.2 Abbott (US) Business Overview
13.1.3 Abbott (US) Renal Disease Introduction
13.1.4 Abbott (US) Revenue in Renal Disease Business (2015-2020))
13.1.5 Abbott (US) Recent Development
13.2 Amgen Inc. (US)
13.2.1 Amgen Inc. (US) Company Details
13.2.2 Amgen Inc. (US) Business Overview
13.2.3 Amgen Inc. (US) Renal Disease Introduction
13.2.4 Amgen Inc. (US) Revenue in Renal Disease Business (2015-2020)
13.2.5 Amgen Inc. (US) Recent Development
13.3 Baxter (US)
13.3.1 Baxter (US) Company Details
13.3.2 Baxter (US) Business Overview
13.3.3 Baxter (US) Renal Disease Introduction
13.3.4 Baxter (US) Revenue in Renal Disease Business (2015-2020)
13.3.5 Baxter (US) Recent Development
13.4 Bristol-Myers Squibb Company (US)
13.4.1 Bristol-Myers Squibb Company (US) Company Details
13.4.2 Bristol-Myers Squibb Company (US) Business Overview
13.4.3 Bristol-Myers Squibb Company (US) Renal Disease Introduction
13.4.4 Bristol-Myers Squibb Company (US) Revenue in Renal Disease Business (2015-2020)
13.4.5 Bristol-Myers Squibb Company (US) Recent Development
13.5 Keryx Biopharmaceuticals(US)
13.5.1 Keryx Biopharmaceuticals(US) Company Details
13.5.2 Keryx Biopharmaceuticals(US) Business Overview
13.5.3 Keryx Biopharmaceuticals(US) Renal Disease Introduction
13.5.4 Keryx Biopharmaceuticals(US) Revenue in Renal Disease Business (2015-2020)
13.5.5 Keryx Biopharmaceuticals(US) Recent Development
13.6 NephroGenex(US)
13.6.1 NephroGenex(US) Company Details
13.6.2 NephroGenex(US) Business Overview
13.6.3 NephroGenex(US) Renal Disease Introduction
13.6.4 NephroGenex(US) Revenue in Renal Disease Business (2015-2020)
13.6.5 NephroGenex(US) Recent Development
13.7 Novartis AG (Switzerland)
13.7.1 Novartis AG (Switzerland) Company Details
13.7.2 Novartis AG (Switzerland) Business Overview
13.7.3 Novartis AG (Switzerland) Renal Disease Introduction
13.7.4 Novartis AG (Switzerland) Revenue in Renal Disease Business (2015-2020)
13.7.5 Novartis AG (Switzerland) Recent Development
13.8 Pfizer Inc.(US)
13.8.1 Pfizer Inc.(US) Company Details
13.8.2 Pfizer Inc.(US) Business Overview
13.8.3 Pfizer Inc.(US) Renal Disease Introduction
13.8.4 Pfizer Inc.(US) Revenue in Renal Disease Business (2015-2020)
13.8.5 Pfizer Inc.(US) Recent Development
13.9 Sanofi (France)
13.9.1 Sanofi (France) Company Details
13.9.2 Sanofi (France) Business Overview
13.9.3 Sanofi (France) Renal Disease Introduction
13.9.4 Sanofi (France) Revenue in Renal Disease Business (2015-2020)
13.9.5 Sanofi (France) Recent Development
13.10 Shire Pharmaceuticals Limited (Republic of Ireland)
13.10.1 Shire Pharmaceuticals Limited (Republic of Ireland) Company Details
13.10.2 Shire Pharmaceuticals Limited (Republic of Ireland) Business Overview
13.10.3 Shire Pharmaceuticals Limited (Republic of Ireland) Renal Disease Introduction
13.10.4 Shire Pharmaceuticals Limited (Republic of Ireland) Revenue in Renal Disease Business (2015-2020)
13.10.5 Shire Pharmaceuticals Limited (Republic of Ireland) Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Renal Disease Key Market Segments
Table 2. Key Players Covered: Ranking by Renal Disease Revenue
Table 3. Ranking of Global Top Renal Disease Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Renal Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Acute Kidney Problems
Table 6. Key Players of Chronic Kidney Diseases
Table 7. Key Players of Others
Table 8. Global Renal Disease Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Renal Disease Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Renal Disease Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Renal Disease Market Share by Regions (2015-2020)
Table 12. Global Renal Disease Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Renal Disease Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Renal Disease Market Growth Strategy
Table 18. Main Points Interviewed from Key Renal Disease Players
Table 19. Global Renal Disease Revenue by Players (2015-2020) (Million US$)
Table 20. Global Renal Disease Market Share by Players (2015-2020)
Table 21. Global Top Renal Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Disease as of 2019)
Table 22. Global Renal Disease by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Renal Disease Product Solution and Service
Table 25. Date of Enter into Renal Disease Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Renal Disease Market Size by Type (2015-2020) (Million US$)
Table 28. Global Renal Disease Market Size Share by Type (2015-2020)
Table 29. Global Renal Disease Revenue Market Share by Type (2021-2026)
Table 30. Global Renal Disease Market Size Share by Application (2015-2020)
Table 31. Global Renal Disease Market Size by Application (2015-2020) (Million US$)
Table 32. Global Renal Disease Market Size Share by Application (2021-2026)
Table 33. North America Key Players Renal Disease Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Renal Disease Market Share (2019-2020)
Table 35. North America Renal Disease Market Size by Type (2015-2020) (Million US$)
Table 36. North America Renal Disease Market Share by Type (2015-2020)
Table 37. North America Renal Disease Market Size by Application (2015-2020) (Million US$)
Table 38. North America Renal Disease Market Share by Application (2015-2020)
Table 39. Europe Key Players Renal Disease Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Renal Disease Market Share (2019-2020)
Table 41. Europe Renal Disease Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Renal Disease Market Share by Type (2015-2020)
Table 43. Europe Renal Disease Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Renal Disease Market Share by Application (2015-2020)
Table 45. China Key Players Renal Disease Revenue (2019-2020) (Million US$)
Table 46. China Key Players Renal Disease Market Share (2019-2020)
Table 47. China Renal Disease Market Size by Type (2015-2020) (Million US$)
Table 48. China Renal Disease Market Share by Type (2015-2020)
Table 49. China Renal Disease Market Size by Application (2015-2020) (Million US$)
Table 50. China Renal Disease Market Share by Application (2015-2020)
Table 51. Japan Key Players Renal Disease Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Renal Disease Market Share (2019-2020)
Table 53. Japan Renal Disease Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Renal Disease Market Share by Type (2015-2020)
Table 55. Japan Renal Disease Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Renal Disease Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Renal Disease Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Renal Disease Market Share (2019-2020)
Table 59. Southeast Asia Renal Disease Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Renal Disease Market Share by Type (2015-2020)
Table 61. Southeast Asia Renal Disease Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Renal Disease Market Share by Application (2015-2020)
Table 63. India Key Players Renal Disease Revenue (2019-2020) (Million US$)
Table 64. India Key Players Renal Disease Market Share (2019-2020)
Table 65. India Renal Disease Market Size by Type (2015-2020) (Million US$)
Table 66. India Renal Disease Market Share by Type (2015-2020)
Table 67. India Renal Disease Market Size by Application (2015-2020) (Million US$)
Table 68. India Renal Disease Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Renal Disease Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Renal Disease Market Share (2019-2020)
Table 71. Central & South America Renal Disease Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Renal Disease Market Share by Type (2015-2020)
Table 73. Central & South America Renal Disease Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Renal Disease Market Share by Application (2015-2020)
Table 75. Abbott (US) Company Details
Table 76. Abbott (US) Business Overview
Table 77. Abbott (US) Product
Table 78. Abbott (US) Revenue in Renal Disease Business (2015-2020) (Million US$)
Table 79. Abbott (US) Recent Development
Table 80. Amgen Inc. (US) Company Details
Table 81. Amgen Inc. (US) Business Overview
Table 82. Amgen Inc. (US) Product
Table 83. Amgen Inc. (US) Revenue in Renal Disease Business (2015-2020) (Million US$)
Table 84. Amgen Inc. (US) Recent Development
Table 85. Baxter (US) Company Details
Table 86. Baxter (US) Business Overview
Table 87. Baxter (US) Product
Table 88. Baxter (US) Revenue in Renal Disease Business (2015-2020) (Million US$)
Table 89. Baxter (US) Recent Development
Table 90. Bristol-Myers Squibb Company (US) Company Details
Table 91. Bristol-Myers Squibb Company (US) Business Overview
Table 92. Bristol-Myers Squibb Company (US) Product
Table 93. Bristol-Myers Squibb Company (US) Revenue in Renal Disease Business (2015-2020) (Million US$)
Table 94. Bristol-Myers Squibb Company (US) Recent Development
Table 95. Keryx Biopharmaceuticals(US) Company Details
Table 96. Keryx Biopharmaceuticals(US) Business Overview
Table 97. Keryx Biopharmaceuticals(US) Product
Table 98. Keryx Biopharmaceuticals(US) Revenue in Renal Disease Business (2015-2020) (Million US$)
Table 99. Keryx Biopharmaceuticals(US) Recent Development
Table 100. NephroGenex(US) Company Details
Table 101. NephroGenex(US) Business Overview
Table 102. NephroGenex(US) Product
Table 103. NephroGenex(US) Revenue in Renal Disease Business (2015-2020) (Million US$)
Table 104. NephroGenex(US) Recent Development
Table 105. Novartis AG (Switzerland) Company Details
Table 106. Novartis AG (Switzerland) Business Overview
Table 107. Novartis AG (Switzerland) Product
Table 108. Novartis AG (Switzerland) Revenue in Renal Disease Business (2015-2020) (Million US$)
Table 109. Novartis AG (Switzerland) Recent Development
Table 110. Pfizer Inc.(US) Business Overview
Table 111. Pfizer Inc.(US) Product
Table 112. Pfizer Inc.(US) Company Details
Table 113. Pfizer Inc.(US) Revenue in Renal Disease Business (2015-2020) (Million US$)
Table 114. Pfizer Inc.(US) Recent Development
Table 115. Sanofi (France) Company Details
Table 116. Sanofi (France) Business Overview
Table 117. Sanofi (France) Product
Table 118. Sanofi (France) Revenue in Renal Disease Business (2015-2020) (Million US$)
Table 119. Sanofi (France) Recent Development
Table 120. Shire Pharmaceuticals Limited (Republic of Ireland) Company Details
Table 121. Shire Pharmaceuticals Limited (Republic of Ireland) Business Overview
Table 122. Shire Pharmaceuticals Limited (Republic of Ireland) Product
Table 123. Shire Pharmaceuticals Limited (Republic of Ireland) Revenue in Renal Disease Business (2015-2020) (Million US$)
Table 124. Shire Pharmaceuticals Limited (Republic of Ireland) Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Renal Disease Market Share by Type: 2020 VS 2026
Figure 2. Acute Kidney Problems Features
Figure 3. Chronic Kidney Diseases Features
Figure 4. Others Features
Figure 5. Global Renal Disease Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Research Center Case Studies
Figure 9. Others Case Studies
Figure 10. Renal Disease Report Years Considered
Figure 11. Global Renal Disease Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Renal Disease Market Share by Regions: 2020 VS 2026
Figure 13. Global Renal Disease Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Renal Disease Market Share by Players in 2019
Figure 16. Global Top Renal Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Disease as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Renal Disease Revenue in 2019
Figure 18. North America Renal Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Renal Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Renal Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Renal Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Renal Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Renal Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Renal Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
慢性腎臓病（CKD）の世界市場（～2026年） Market Analysis and Insights: Global Chronic Kidney Disease (CKD) Market The global Chronic Kidney Disease (CKD) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chronic Kidney Disease (CKD) Scope and Market Size Chroni…- 腎臓/腎がん治療薬の世界市場（～2026年） Kidney/Renal Cancer Drugs are used to cure kidney cancers. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors bo…
- 末期腎疾患（ESRD）治療薬の世界市場（～2026年） Market Analysis and Insights: Global End-Stage Renal Disease (ESRD) Drugs Market The global End-Stage Renal Disease (ESRD) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global End-Stage Renal Disease (ESRD) Drugs Scop…
- 急性腎不全治療薬の世界市場（～2026年） Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body. Acute re…
- 体外血液治療の世界市場（～2026年） The extracorporeal blood treatment is a type of filtration method used to remove many toxins from the blood. The demand for extracorporeal blood treatment is expected to upsurge owing to the growth of kidney diseases. Market Analysis and Insights: Global Extracorporeal Blood Treatment Market The glo…